Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Daniel Sawler"'
Publikováno v:
Leukemia Research Reports, Vol 22, Iss , Pp 100477- (2024)
Acute myeloid leukemia (AML) patients undergoing induction chemotherapy receive transfusion support to manage severe cytopenias and associated sequelae. Jehovah's Witness (JW) patients typically decline transfusion of most or all blood products. This
Externí odkaz:
https://doaj.org/article/374f3669f68c4c4daa58e1907846693f
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 6, Pp n/a-n/a (2021)
Abstract Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out
Externí odkaz:
https://doaj.org/article/1dad7fdb5a754d7c9ef91c4b7a9df202
Autor:
M. Dawn Goodyear, Arabesque Parker, Daniel Sawler, Haowei Linda Sun, Joanne Britto, Mohammad Karkhaneh, Chris Wynick
Publikováno v:
Thrombosis Research. 196:335-339
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy (TMA) that requires prompt plasma exchange. Clinical prediction tools may facilitate decision-making in institutions with delayed turnaround time or limited ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c510817b38846d6e35944494f583aba5
https://doi.org/10.1016/j.thromres.2020.09.012
https://doi.org/10.1016/j.thromres.2020.09.012
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 6, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Adenoviral‐vector based vaccines for coronavirus disease 2019 (COVID‐19) have been linked with a thrombotic syndrome, vaccine‐induced thrombotic thrombocytopenia (VITT). A key clinical question is whether VITT can be reliably ruled out by the a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072d4b46756d4ecff35c9f72164b7dca
https://doaj.org/article/1dad7fdb5a754d7c9ef91c4b7a9df202
https://doaj.org/article/1dad7fdb5a754d7c9ef91c4b7a9df202
Publikováno v:
Thrombosis research. 193
Background Thrombotic thrombocytopenic purpura (TTP) is a thrombotic microangiopathy (TMA) with significant morbidity and mortality. Guidelines recommend initiating plasma exchange within 4–8 h of suspected diagnosis. It is unclear what are real-wo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56b46d957dc68632d5e440de076b7dfb
https://pubmed.ncbi.nlm.nih.gov/32521335
https://pubmed.ncbi.nlm.nih.gov/32521335
Autor:
Arabesque Parker, Mohammad Karkhaneh, Chris Wynick, Dawn Goodyear, Daniel Sawler, Haowei Linda Sun, Joanne Britto
Publikováno v:
Blood. 134:2379-2379
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening thrombotic microangiopathy (TMA), characterized by widespread intravascular thrombosis. Diagnosis of TTP is confirmed by a deficiency in ADAMTS13. However, given the urgency of prompt di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88f218a1ee4cf37c865e085439e7befe
https://doi.org/10.1182/blood-2019-126354
https://doi.org/10.1182/blood-2019-126354
Publikováno v:
American Journal of Gastroenterology. 107:S485
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::724245be5f7506743dd4ffd119e6e74e
https://doi.org/10.14309/00000434-201210001-01218
https://doi.org/10.14309/00000434-201210001-01218